TROXERUTIN AS A POTENTIAL THROMBIN INHIBITING DRUG
| Main Authors: | L.T.T. Tobias, S.C.G. Gomes, L.L. Borges, T.M. Alquimim, L.S.F. Sá, M.H.D.S. Pitta, L.C. Pina, L.R. Pedro, R.M.M.O. Filho, G.C. Pina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-11-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920304569 |
Similar Items
-
Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cerebral ischemia/reperfusion injury by down-regulating caspase molecules
by: Sui R, et al.
Published: (2019-08-01) -
Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?
by: F. Fahmideh, et al.
Published: (2022-08-01) -
Evaluating the Fluorescence Quenching of Troxerutin for Commercial UV Sunscreen Filters
by: Jack Dalton, et al.
Published: (2024-10-01) -
Transcriptomic analysis of gene expression in mice treated with troxerutin.
by: Yuerong Wang, et al.
Published: (2017-01-01) -
Noncompetitive inhibitor of thrombin.
by: Koh, C, et al.
Published: (2009)